{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:39:08Z","timestamp":1786441148784,"version":"build-2736575974"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Gastric cancer remains a highly lethal malignancy characterized by late diagnosis, limited therapeutic responsiveness, and a profoundly immunosuppressive tumor microenvironment. Among the diverse cellular components shaping this ecosystem, tumor-associated macrophages (TAMs) have emerged as central orchestrators of gastric carcinogenesis, metastatic dissemination, and therapeutic resistance. TAMs promote tumor initiation through inflammatory recruitment and polarization, facilitate invasion and angiogenesis via cytokines, matrix-remodeling enzymes, and exosomal cargo, and impair antitumor immunity by suppressing T-cell and natural killer cell function. In addition, TAMs contribute to resistance to immune checkpoint blockade by sustaining an immunosuppressive tumor immune microenvironment enriched in Tregs, myeloid-derived suppressor cells, and inhibitory mediators such as TGF-\u03b2, IL-10, and PD-L1. Recent advances further highlight the translational promise of macrophage-targeted strategies, including polarization reprogramming, recruitment blockade, and chimeric antigen receptor macrophage therapy. Previous reviews primarily focus on the general biological roles of TAMs, this review synthesizes newly emerging mechanisms of TAM-mediated immunotherapy resistance, including spatial heterogeneity, stromal-vascular remodeling, and exosomal crosstalk, with the latest clinical advances in macrophage-directed immunotherapies. We specifically highlight the translational potential and current clinical trial landscape of chimeric antigen receptor macrophage (CAR-M) therapy and targeted reprogramming strategies, providing a forward-looking perspective on overcoming immune checkpoint blockade resistance in gastric cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1711076","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:19:40Z","timestamp":1786439980000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune modulation in gastric cancer: from macrophage polarization to immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaofeng","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, The Second Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangwei","family":"Zong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Hospital of Jilin University","place":["Changchun, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal surgery, Tonghua Central Hospital","place":["Tonghua, Jilin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(25)01635-6","article-title":"The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-443-15609-0.00017-9","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41419-025-07385-7","article-title":"Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies","volume":"16","author":"Luo","year":"2025","journal-title":"Cell Death Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1285343","article-title":"Resistance to immune checkpoint inhibitors in gastric cancer","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.992060","article-title":"An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer","volume":"13","author":"Wang","year":"2022"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1386","article-title":"Tumour-associated macrophages in gastric cancer: From function and mechanism to application","volume":"13","author":"Li","year":"2023","journal-title":"Clin Transl Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333617","article-title":"CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003890","article-title":"Spatial transcriptomics of macrophage infiltration in non-small cell lung cancer reveals determinants of sensitivity and resistance to anti-PD1\/PD-L1 antibodies","volume":"10","author":"Larroquette","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41698-024-00660-4","article-title":"Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census","volume":"8","author":"Wei","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28238","article-title":"IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells","volume":"13","author":"Tran","year":"2022","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332901","article-title":"Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages","volume":"74","author":"Lee","year":"2025","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-23-1012","article-title":"Dynamic changes in macrophage subtypes during lung cancer progression and metastasis at single-cell resolution","volume":"15","author":"Wang","year":"2023","journal-title":"J Thorac Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1628543","article-title":"Inflammatory factors collaboratively link Helicobacter pylori-induced gastritis to gastric cancer","volume":"16","author":"Zhang","year":"2025"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2008.105","article-title":"Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells","volume":"27","author":"Oguma","year":"2008","journal-title":"EMBO J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1558091","article-title":"Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy","volume":"16","author":"He","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.14740\/gr1636","article-title":"Effects of Helicobacter pylori Infection on the Prognosis of Chronic Atrophic Gastritis by Inducing the Macrophage Polarization","volume":"16","author":"Zhao","year":"2023","journal-title":"Gastroenterol Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-02017-7","article-title":"Helicobacter pylori infection promotes M1 macrophage polarization and gastric inflammation by activation of NLRP3 inflammasome via TNF\/TNFR1 axis","volume":"23","author":"Fei","year":"2025","journal-title":"Cell Commun Signaling"},{"key":"B21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ph17070951","article-title":"Cancer cell secreted legumain promotes gastric cancer resistance to anti-PD-1 immunotherapy by enhancing macrophage M2 polarization","volume":"17","author":"Pei","year":"2024","journal-title":"Pharm (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1186\/s12885-024-12672-1","article-title":"Gastric cancer cell-derived exosomal miR-541-5p induces M2 macrophage polarization through DUSP3\/JAK2\/STAT3 pathway","volume":"24","author":"Xiao","year":"2024","journal-title":"BMC Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1160719","article-title":"Advances in the role of STAT3 in macrophage polarization","volume":"14","author":"Xia","year":"2023","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41467-025-56579-2","article-title":"A humanized NOVA1 splicing factor alters mouse vocal communications","volume":"16","author":"Tajima","year":"2025","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2424490","article-title":"Extracellular vesicle-packaged miR-4253 secreted by cancer-associated fibroblasts facilitates cell proliferation in gastric cancer by inducing macrophage M2 polarization","volume":"25","author":"Duan","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193164","article-title":"M2 macrophage polarization mediated by complement C3 from hedgehog-activated fibroblasts establishes an immunosuppressive niche in gastric cancer","volume":"17","author":"Lou","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","article-title":"Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression","volume":"23","author":"Deng","year":"2024","journal-title":"Mol Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-024-01486-6","article-title":"Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis","volume":"27","author":"Li","year":"2024","journal-title":"Gastric Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/path.6151","article-title":"Spatial transcriptomics reveals heterogeneity of macrophages in the tumor microenvironment of granulomatous slack skin","volume":"261","author":"Feng","year":"2023","journal-title":"J Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the spatiotemporal heterogeneity of tumor-associated macrophages","volume":"23","author":"Chu","year":"2024","journal-title":"Mol Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1327281","article-title":"Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment","volume":"15","author":"Qiu","year":"2024"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1683799","article-title":"Targeting cancer via macrophage-derived exosomal miRNAs: implications for tumor progression and resistance","volume":"16","author":"Ramalingam","year":"2025"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1540643","article-title":"Exosomes: their role and therapeutic potential in overcoming drug resistance of gastrointestinal cancers","volume":"15","author":"Liu","year":"2025"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2146839","article-title":"Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253","volume":"22","author":"Yu","year":"2023","journal-title":"Cell Cycle"},{"key":"B36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40001-025-02329-5","article-title":"Tumor-associated macrophage-derived exosome miR-194 confers cisplatin resistance in GC cells","volume":"30","author":"Zhou","year":"2025","journal-title":"Eur J Med Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.virol.2020.05.011","article-title":"Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer","volume":"548","author":"Song","year":"2020","journal-title":"Virology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109096","article-title":"MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K\/AKT\/Snail pathway","volume":"117","author":"Liu","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705395105","article-title":"Progenitor\/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling","volume":"105","author":"Tang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13847","article-title":"Helicobacter pylori-induced exosomal MET educates tumour-associated macrophages to promote gastric cancer progression","volume":"22","author":"Che","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1549694","article-title":"Targeting tumor-associated macrophages in gastric cancer progression and therapy: insights from molecular mechanisms to therapeutic applications","volume":"16","author":"Wan","year":"2025","journal-title":"Front Pharmacol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202508352","article-title":"An LCN2-dependent positive-feedback loop between gastric cancer cells and tumor-associated-macrophages mediates lymphangiogenesis and lymphatic metastasis","volume":"12","author":"Huang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01795.x","article-title":"Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer","volume":"102","author":"Ma","year":"2011","journal-title":"Cancer Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.793805","article-title":"Semaphorins as potential immune therapeutic targets for cancer","volume":"12","author":"Jiang","year":"2022"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1564572","article-title":"Inflammation and cancer: molecular mechanisms and clinical consequences","volume":"15","author":"Akk\u0131z","year":"2025"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091406","article-title":"VEGF-C and lymphatic vessel density in tumor tissue of gastric cancer: correlations with pathoclinical features and prognosis","volume":"17","author":"Szajewski","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1658795","article-title":"Progress in targeting tumor-associated macrophages in cancer immunotherapy","volume":"16","author":"Xia","year":"2025","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7554\/elife.80721","article-title":"Arginase 1 is a key driver of immune suppression in pancreatic cancer","volume":"12","author":"Menjivar","year":"2023","journal-title":"Elife"},{"key":"B51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-025-02481-w","article-title":"Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy","volume":"24","author":"Coelho","year":"2025","journal-title":"Mol Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40364-023-00538-w","article-title":"Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers","volume":"11","author":"Zhou","year":"2023","journal-title":"biomark Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2023.2210959","article-title":"M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance","volume":"12","author":"Zheng","year":"2023","journal-title":"Oncoimmunology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-1255","article-title":"Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer","volume":"10","author":"Li","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1517495","article-title":"Exosome tropism and various pathways in lung cancer metastasis","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18195","article-title":"Expression of matrix metalloproteinase-9 in gastric cancer","volume":"13","author":"R","year":"2021","journal-title":"Cureus"},{"key":"B57","article-title":"Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2\/MMP9-dependent manner","volume":"11","author":"Xu","year":"2019","journal-title":"Am J Transl Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1431598","article-title":"Inhibition of IL-10 and TGF-\u03b2 receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells","volume":"14","author":"Thepmalee","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050930","article-title":"B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma","volume":"203","author":"Kryczek","year":"2006","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/cells14100741","article-title":"Tumor-associated macrophages: polarization, immunoregulation, and immunotherapy","volume":"14","author":"Saeed","year":"2025","journal-title":"Cells"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers (Basel)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1061394","article-title":"TGF-\u03b2: A novel predictor and target for anti-PD-1\/PD-L1 therapy","volume":"13","author":"Yi","year":"2022"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/s41467-023-40398-4","article-title":"Combined PD-L1\/TGF\u03b2 blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors","volume":"14","author":"Castiglioni","year":"2023","journal-title":"Nat Commun"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00828","article-title":"Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies","volume":"8","author":"Genard","year":"2017","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1618591","article-title":"Identification of a stromal immunosuppressive barrier orchestrated by SPP1+\/C1QC+ macrophages and CD8+ exhausted T cells driving gastric cancer immunotherapy resistance","volume":"16","author":"Ma","year":"2025"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1817573","article-title":"The CSF1+ tumor cell\u2013SPP1+ macrophage axis drives gastric cancer progression and immunotherapy resistance","volume":"17","author":"Zhang","year":"2026"},{"key":"B70","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12967-023-04688-1","article-title":"Potential crosstalk between SPP1\u2009+\u2009TAMs and CD8\u2009+\u2009exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer","volume":"22","author":"Du","year":"2024","journal-title":"J Transl Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41698-025-00967-w","article-title":"Multi-omics analyses reveal interactions between GREM1+ fibroblasts and SPP1+ macrophages in gastric cancer","volume":"9","author":"Qiu","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12672-023-00795-z","article-title":"Exploring oncogenes for renal clear cell carcinoma based on G protein-coupled receptor-associated genes","volume":"14","author":"Zhu","year":"2023","journal-title":"Discov Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111735","article-title":"Molecular mechanism for Malignant progression of gastric cancer within the tumor microenvironment","volume":"25","author":"Matsuoka","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-026-02572-2","article-title":"Tumor microenvironment dynamics in gastric cancer pathogenesis and therapeutic resistance","volume":"25","author":"Lu","year":"2026","journal-title":"Mol Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-024-01907-3","article-title":"Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization","volume":"73","author":"Sezginer","year":"2024","journal-title":"Inflammation Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1655176","article-title":"Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis","volume":"16","author":"Mukherjee","year":"2025"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216351","article-title":"Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer","volume":"572","author":"Mao","year":"2023","journal-title":"Cancer Lett"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1412461","article-title":"Role of post-translational modifications of Sp1 in cancer: state of the art","volume":"12","author":"Sun","year":"2024"},{"key":"B80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s43556-024-00225-8","article-title":"Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer","volume":"5","author":"Yin","year":"2024","journal-title":"Mol BioMed"},{"key":"B81","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion","volume":"13","author":"Lu","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-026-01053-4","article-title":"Inhibiting CXCL12\/CXCR4 axis enhances T cell activity in gastric cancer","author":"Ling","year":"2026","journal-title":"Cancer Gene Ther"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6959","article-title":"Regulation of regulatory T cells and tumor-associated macrophages in gastric cancer tumor microenvironment","volume":"13","author":"Shaopeng","year":"2024","journal-title":"Cancer Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.668707","article-title":"Poor prognosis and therapeutic responses in LILRB1-expressing M2 macrophages-enriched gastric cancer patients","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17050795","article-title":"Cancer-associated fibroblasts genes and transforming growth factor beta pathway in gastric cancer for novel therapeutic strategy","volume":"17","author":"Minoura","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101551","article-title":"The role of the transforming growth factor-\u03b2 signaling pathway in gastrointestinal cancers","volume":"13","author":"Matsuoka","year":"2023","journal-title":"Biomolecules"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1158863","article-title":"Cancer-associated fibroblasts refine the classifications of gastric cancer with distinct prognosis and tumor microenvironment characteristics","volume":"13","author":"Gu","year":"2023","journal-title":"Front Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1340124","article-title":"Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer","volume":"11","author":"Ozmen","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100843","article-title":"Proteomic heterogeneity of the extracellular matrix identifies histologic subtype-specific fibroblast in gastric cancer","volume":"23","author":"Lee","year":"2024","journal-title":"Mol Cell Proteomics"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102113","article-title":"Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling","volume":"49","author":"Zhang","year":"2024","journal-title":"Transl Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14586-x","article-title":"Cancer-associated fibroblast-derived IL-8 upregulates PD-L1 expression in gastric cancer through the NF-\u03baB pathway","volume":"31","author":"Lou","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1085","article-title":"Inhibition of CXCL12\/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma","volume":"6","author":"Xue","year":"2017","journal-title":"Cancer Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.matbio.2024.06.004","article-title":"Cancer-associated fibroblasts promote proliferation, angiogenesis, metastasis and immunosuppression in gastric cancer","volume":"132","author":"Li","year":"2024","journal-title":"Matrix Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.37349\/etat.2025.1002312","article-title":"Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control","volume":"6","author":"Marimuthu","year":"2025","journal-title":"Explor Target Antitumor Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-2025-491","article-title":"NKAP overexpression promotes gastric cancer immune escape by inducing IL-10 secretion from mature dendritic cells during anti-PD-L1 therapy","volume":"16","author":"Yan","year":"2025","journal-title":"J Gastrointest Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09000-3","article-title":"STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity","volume":"643","author":"Zhou","year":"2025","journal-title":"Nature"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/biomedicines14071588","article-title":"CD86 in dendritic cell-mediated cancer immunity: from maturation marker to functional regulator","volume":"14","author":"Wu","year":"2026"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fcell.2023.1261749","article-title":"Tumour-associated macrophages: versatile players in the tumour microenvironment","volume":"11","author":"Ji","year":"2023"},{"key":"B100","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","article-title":"Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications","volume":"14","author":"Fang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"Leone","year":"2024"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/biom13060886","article-title":"Gastric cancer vascularization and the contribution of reactive oxygen species","volume":"13","author":"Biagioni","year":"2023","journal-title":"Biomolecules"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1325538","article-title":"The relationship between autoimmune thyroid disease, thyroid nodules and sleep traits: a Mendelian randomization study","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41419-021-04266-7","article-title":"Natriuretic peptide receptor a promotes gastric Malignancy through angiogenesis process","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102045","article-title":"Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting response","volume":"6","author":"Alcindor","year":"2025","journal-title":"Cell Rep Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-20-0591","article-title":"CSF1\/CSF1R signaling inhibitor Pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.690869","article-title":"Defects in macrophage reprogramming in cancer therapy: the negative impact of PD-L1\/PD-1","volume":"12","author":"Cai","year":"2021","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-18-0061","article-title":"A CD40 agonist and PD-1 antagonist antibody reprogram the microenvironment of nonimmunogenic tumors to allow T-cell-mediated anticancer activity","volume":"7","author":"Ma","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2018.1470729","article-title":"Recruitment of CCR2(+) tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer","volume":"7","author":"Grossman","year":"2018","journal-title":"Oncoimmunology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-023-00012-y","article-title":"Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer","volume":"16","author":"Che","year":"2024","journal-title":"EMBO Mol Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-025-01764-5","article-title":"Updated data of CLL1 CAR-T cell therapy in adult patients with relapsed\/refractory acute myeloid leukemia","volume":"18","author":"Zhang","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029532","article-title":"CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia","volume":"146","author":"Geyer","year":"2025","journal-title":"Blood"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14030654","article-title":"Targeting T-cells for cancer treatment: current clinical strategies and challenges","volume":"14","author":"Rotte","year":"2026","journal-title":"Biomedicines"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2026017","article-title":"CAR-macrophages: a new chapter in cancer immunotherapy","volume":"58","author":"Tang","year":"2026","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02548-7","article-title":"CD86 costimulation enhances the antitumor activity of NKG2D CAR-macrophages and synergizes with anti-PD-L1 therapy to suppress prostate cancer progression","volume":"23","author":"Ibrahim","year":"2025","journal-title":"Cell Commun Signal"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2519819123","article-title":"Synthetic SIGLEC9-based chimeric switch receptor augments the efficacy of CAR macrophages against glioblastoma","volume":"123","author":"Fu","year":"2026","journal-title":"Proc Natl Acad Sci USA"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1726329","article-title":"Chimeric antigen receptor macrophages therapy for glioblastoma: challenges and opportunities from preclinical evidence to clinical translation","volume":"17","author":"Zhai","year":"2026","journal-title":"Front Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"706","DOI":"10.21417\/js2024nc","article-title":"Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models","volume":"16","author":"Pierini","year":"2025","journal-title":"Nat Commun"},{"key":"B120","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12967-023-04479-8","article-title":"The application of HER2 and CD47 CAR-macrophage in ovarian cancer","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012463","article-title":"Engineering TME-activated CD47-specific CAR macrophage via Arg1 promoter for safe and effective solid tumor immunotherapy","volume":"13","author":"Du","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B122","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1038\/s41467-025-59326-9","article-title":"CAR macrophages with built-in CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat Commun"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01220-3","article-title":"Silencing of SIRP\u03b1 enhances the antitumor efficacy of CAR-M in solid tumors","volume":"21","author":"Zhang","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02319-6","article-title":"Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer","volume":"129","author":"Dong","year":"2023","journal-title":"Br J Cancer"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102621","article-title":"Bacterial vesicles from intratumoral L. salivarius enhance PD-1 blockade via FPR1-mediated macrophage polarization in gastric cancer","volume":"7","author":"Yu","year":"2026","journal-title":"Cell Rep Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1711076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:19:42Z","timestamp":1786439982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1711076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":125,"alternative-id":["10.3389\/fimmu.2026.1711076"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1711076","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"article-number":"1711076"}}